Molecular Diagnostics in Genetic Testing Space Examined in New TriMark Publications Study Available at MarketPublishers.com
28 Aug 2013 • by Natalie Aster
LONDON – Molecular diagnostics in genetic testing is growing at a rapid pace, bringing advanced analytical methods assisting in the diagnosis and treatment of various genetic disorders. Breakthroughs in proteomics and genomics in tandem with the development of microarray technologies for measuring analytes in the blood and various body tissues are the major factors driving remarkable growth in the segment. Among the most significant developments one can name the integration of specialty labs and gene expression profiling into clinical practices, the introduction and fast advancement of cell-free fetal DNA prenatal testing, the expansion of companion diagnostics for drug discovery and development, the widespread installed base of automated instruments for molecular testing as well as the advancement of personalized medicine. Genetic testing is molecular diagnostics’ one of the most fruitful sectors, which is likely to be an area of corporate change and high growth through to 2018.
New cutting-edge study “Molecular Diagnostics in Genetic Testing” elaborated by TriMark Publications thoroughly examines the emerging field of molecular diagnostics in genetic testing. The report provides in-depth analysis of the size and growth of the molecular diagnostics in genetic testing market, including the factors that influence the various market segments within it and the dollar volume of sales, both in the United States and worldwide. Furthermore, the research is enriched with detailed profiles of the leading companies focused on the molecular diagnostics for genetic testing industry.
Companies discussed include: Agendia, ArcticDx, Inc., Arcxis Biotechnologies, Biodesix, bioTheranostics (AviaraDx), Cancer Genetics, Inc., Clarient, Inc. (GE Healthcare), CombiMatrix Corporation, Epigenomics, Exact Sciences Corporation, Exagen Diagnostics, Inc., Exiqon, Ferrer inCode, Genomic Health, Inc., Genoptix, Inc., InterGenetics, Inc., LabCorp, Myriad Genetics, Inc., Nanostring, Neogenomics, Nuvera Biosciences, Orion Genomics, QIAGEN NV, Rosetta Genomics Ltd., Seegene, Sequenom, Inc., SABiosciences Corporation (Qiagen), Source MDx, Targeted Molecular Diagnostics, Trovagene, Inc.
Molecular Diagnostics in Genetic Testing
Published: August, 2013
Price: US$ 3,400.00
Other Cutting-Edge Market Research Reports by TriMark Publications Encompass:
- Biologics and Biosimilars World Markets
- Bioseparation Systems for Global Biopharmaceutical Markets
- Companion Biomarkers in Drug Development
- Stem Cell Markets
- Point of Care Diagnostic Testing World Markets
- Medical Imaging Markets
More new market research reports by the publisher can be found at TriMark Publications page.